Prime Medicine, Inc. (NASDAQ: PRME) Stock Information | RedChip

Prime Medicine, Inc. (NASDAQ: PRME)


$2.9250
-0.2250 ( -5.95% ) 432.6K

Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.

Market Data


Open


$2.9250

Previous close


$3.1500

Volume


432.6K

Market cap


$392.83M

Day range


$2.9000 - $3.1750

52 week range


$2.5600 - $9.7700

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Feb 20, 2024
8-k 8K-related 18 Feb 16, 2024
8-k 8K-related 14 Feb 14, 2024
3 Insider transactions 2 Jan 19, 2024
4 Insider transactions 1 Jan 19, 2024
8-k 8K-related 43 Jan 08, 2024
8-k 8K-related 12 Jan 05, 2024
8-k 8K-related 13 Jan 05, 2024

Latest News